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Theta oscillations in the limbic system depend on the integrity of the
medial septum. The different populations of medial septal neurons
(cholinergic and GABAergic) are assumed to affect different aspects
of theta oscillations. Using optogenetic stimulation of cholinergic
neurons in ChAT-Cre mice, we investigated their effects on hippo-
campal local field potentials in both anesthetized and behaving
mice. Cholinergic stimulation completely blocked sharp wave ripples
and strongly suppressed the power of both slow oscillations (0.5–
2 Hz in anesthetized, 0.5–4 Hz in behaving animals) and supratheta
(6–10 Hz in anesthetized, 10–25 Hz in behaving animals) bands. The
same stimulation robustly increased both the power and coherence
of theta oscillations (2–6 Hz) in urethane-anesthetized mice. In be-
having mice, cholinergic stimulation was less effective in the theta
(4–10 Hz) band yet it also increased the ratio of theta/slow oscilla-
tion and theta coherence. The effects on gamma oscillations largely
mirrored those of theta. These findings show that medial septal
cholinergic activation can both enhance theta rhythm and suppress
peri-theta frequency bands, allowing theta oscillations to dominate.
acetylcholine
Subcortical neuromodulators play a critical role in shiftingstates of the brain (1, 2). State changes can occur both during
sleep and in the waking animal and are instrumental in affecting
local circuit computation that supports various functions, including
attention, learning, memory, and action (3–5). The septo-hippo-
campal cholinergic system has been hypothesized to play a critical
role in setting network states in the limbic system (4, 6). ACh can
affect both short- and long-term plasticity of synaptic connections
and provide favorable conditions for encoding information (7–9).
These plastic states are associated with hippocampal theta oscil-
lations (10). High theta states are characterized by increased release
of ACh that varies in a task-dependent manner on the time scale of
seconds (11–13). In contrast, reduced cholinergic activity allows
effective spread of excitation in the recurrent CA3 network, giving
rise to synchronous sharp wave ripples (SPW-R) (14–16).
Inactivation of the medial septum (MS)/diagonal band of Broca
abolishes theta oscillations in the hippocampus and entorhinal
cortex (17) and results in severe learning deficit (18, 19). Similarly,
selective toxin lesion of septal cholinergic neurons produces a sev-
eral-fold decrease of theta power but not its frequency (20). The
phase of the local field potentials (LFP) theta oscillations shifts
from the septal to the temporal pole and in the CA3–CA1 axis by
∼180° (21, 22). Thus, at each point in time neurons residing at
different locations of the three-dimensional structure of the hip-
pocampus spike at different theta phases yet are bound together by
the global theta signal. These numerous sources of theta generators
are believed to be coordinated by the reciprocal connections be-
tween the septum and hippocampus (23), but the nature of this
spatial–temporal coordination is not well understood (24). Both
cholinergic and GABAergic neurons, and a small fraction of
VGlut2 immunoreactive neurons (25), are believed to play a critical
role in such global coordination (26, 27). Although GABAergic
neurons of the MS were demonstrated to be entrained at theta
frequency, identified cholinergic neurons did not show theta-related
discharge pattern (28, 29). Additionally, both GABAergic and
cholinergic neurons are affected by the feedback long-range hip-
pocampo-septal inhibitory connections (30).
Early studies, performed in anesthetized animals, already sug-
gested a critical role for the cholinergic septo-hippocampal pro-
jection in the generation of theta oscillations (6). Indeed, the low-
frequency theta present under urethane anesthesia can be fully
abolished by antimuscarinic drugs (31). In contrast, atropine or
scopolamine fail to abolish theta oscillations during waking ex-
ploration (31, 32), although they affect the theta waveform and its
amplitude-phase depth profile in the hippocampus (33). Although
these previous works are compatible with the hypothesis that the
role of septal cholinergic projections is mainly permissive and
affects theta power without modulating its frequency (20, 26, 28),
direct evidence is missing. The role of septal cholinergic neurons
on gamma oscillation and SPW-R is even less understood (14). To
address these issues, we used optogenetic activation of septal
cholinergic input and examined its impact on hippocampal theta,
peri-theta bands, gamma, and ripple oscillations in both anes-
thetized and freely moving mice.
Significance
Theta oscillations are a prominent rhythm of the brain occur-
ring during active behavior and rapid eye movement sleep and
thought to provide the temporal frame for the encoding of
information. Acetylcholine modulation is a major player in
hippocampal theta rhythm, as demonstrated by lesion and
pharmacological manipulations of cholinergic receptors, yet the
link between the activity of septal cholinergic neurons and the
theta rhythm is not fully understood. We used specific opto-
genetic stimulation of the septo-hippocampal cholinergic neu-
rons in the anesthetized and behaving mouse to decipher the
effects of cholinergic stimulation on hippocampal network ac-
tivity and show that in addition to promoting theta oscillations
it suppresses sharp wave ripples and peri-theta band activity.
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Results
To address the role of the septo-hippocampal cholinergic input,
we used mice expressing light-activated cation channel chan-
nelrhodopsin-2 tagged with a fluorescent protein (ChR2-YFP)
under the control of the choline-acetyl transferase promoter
(ChAT). These mice displayed an intense YFP-positive staining
in MS ChAT neurons, as shown by double immunostaining in
transgenic hybrid (Fig. 1A) and virus-injected mice (Fig. S1A)
and YFP- and ChAT-positive fibers in the target structures of
the MS, including the hippocampus (Fig. S1B).
Light-Responsive Cells in the Medial Septum. First, using urethane-
anesthetized mice, we verified that illumination of the MS induced
a light-entrained activity of putative ChAT neurons. To this end,
we constructed optrodes by placing an etched and sharpened optic
fiber (diameter <10 μm) glued on the shank(s) of a multisite sil-
icon probe (34). Brief pulses of light (10–100 ms) were applied at
0.5 Hz continuously while the optrode was descended into the MS
(Fig. S1D), until responsive units were identified. Responsive
neurons reliably followed trains of pulses (Fig. 1 C, 1) and sine
stimulations between 0.5 and 12 Hz (Fig. 1D), whereas at fre-
quencies >10 Hz spike adaptation was observed (Fig. 1 C, 2). All
light-responsive cells (n = 6 cells from n = 4 mice) had slow
spontaneous firing rates (median firing rate 0.57 Hz, range 0.04–
1.9 Hz). Half of the driven cells significantly increased their firing
frequency in response to a tail pinch although they stayed within
a slow-firing range (<4 Hz; Fig. 1B), consistent with the typical
activity of cholinergic neurons (28, 29).
Hippocampal Responses to MS Stimulation. Whereas cholinergic
neurons faithfully followed the frequency of stimulation, the fre-
quency of theta oscillation in the hippocampus was not affected
(Fig. 1E). To ensure that this effect was not due to the low in-
tensity of light delivered by the optrode (<0.6 mW at the tip), in
subsequent experiments a multimode optic fiber (50- to 105-μm
core, yielding 5–10 mW maximal light intensity) was implanted in
the MS and multisite, linear silicon probes were used to record
hippocampal activity in anesthetized and freely moving mice.
Suppression of hippocampal sharp wave ripples. The most prominent
and consistent effect of optogenetic stimulation of MS cholinergic
neurons was the suppression of SPW-Rs recorded in the CA1
pyramidal layer (Fig. 2). Ripple occurrence was significantly sup-
pressed or abolished during MS stimulation (1–12 Hz, sine stim-
ulation or pulse trains, 1–60 s) in mice recorded either during
urethane anesthesia (n = 6 mice, median suppression −90%, P =
0.0312) or during free behavior (n = 8, median suppression −92%,
P < 0.01). The few surviving SPW-Rs during the stimulation were
similar to ripples detected in control epochs (Fig. S2). The ef-
fective suppression of SPW-Rs demonstrated that MS stimulation
exerted a physiological impact on the operations of hippocampal
circuits in both anesthetized and behaving mice.
Effect on hippocampal LFP power. MS stimulation had an apparently
differential effect on theta oscillations in anesthetized and be-
having mice. Whereas under both conditions MS stimulation
reduced the power in the slow (0.5–2 Hz in anesthetized, 0.5–4 Hz
in behaving animals) and supratheta bands (6–10 Hz in anes-
thetized, 10–25 Hz in behaving animals), it increased theta power
in anesthetized mice but it decreased or had no effect on theta
power in behaving mice (Fig. 3).
Under anesthesia, stimulation of the MS typically switched hip-
pocampal activity from large-amplitude, irregular activity (35) to
a theta state (Fig. 3A). Spectral analysis of 10-s-long stimulation
segments relative to 10-s control segments before stimulation (Fig. 3
B and C) showed that the MS stimulation effect was most prom-
inent at lower frequencies (<30 Hz). Optogenetic stimulation in-
duced a strong increase of power at 3–4 Hz (“urethane theta,” ref.
31), whereas both lower (0.5–2 Hz) and upper (6–10 Hz) neigh-
boring frequency bands were strongly decreased. The impact on
theta was most prominent in stratum lacunosum-moleculare (LM,
Fig. 3C). Across animals, the effect on theta power increase was
significant individually in six of seven anesthetized mice (2–6 Hz;
group median change +1.5 dB, P < 10−21, n = 296 trials; Fig. S3A).
Stimulation also significantly decreased power in the slow oscillation
band (0.5–2 Hz; −3.5 dB, P < 10−31) and in the supratheta band
(6–10 Hz; −0.9 dB, P < 10−11). Optogenetic Q:10stimulation in the MS
of ChAT-cre mice injected by a virus carrying only the fluorescent
reporter enhanced YFP (EYFP) induced no detectable changes in
hippocampal activity (Fig. S4).
The theta/slow oscillation ratio increased in six out of seven
anesthetized mice (group: +207%, P < 10−33). To further analyze
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Fig. 1. Entrainment of MS neurons by blue light stimulation. (A) Left-most
panel: YFP-positive immunostaining in a coronal section of the MS in a ChAT-
ChR2-YFP hybrid transgenic mouse. LS, lateral septum; VDB, ventral diagonal
band. (Scale bar: 200 μm.) Right panels: higher magnification of the MS
(rectangle in left panel), double immunostaining of YFP (green, left), and
ChAT (red, middle), showing their perfect colocalization (overlay, right;
100% overlap in n = 108 and n = 111 neurons in two mice). (Scale bar:
10 μm.) (B) Spontaneous activity of all light-entrained cells. Asterisks indicate
a significant difference in the mean firing rate in response to tail pinch
(mean ± SEM, n = 4 trials, paired t test). (C, 1). Raster plot activity of an
entrained cell in response to 10 Hz (Upper) and 20 Hz (Lower) trains of
optogenetic stimulations (15-ms pulses, blue arrows). (C, 2) The reliability
of spiking decreases at higher frequencies (mean ± SEM, n = 4 neurons).
Asterisks indicate a significantly lower spike occurrence compared with the
first pulse (repeated-measures ANOVA with Bonferroni post-hoc test). (D)
Mean firing rates of MS entrained cells in response to sinusoidal stim-
ulations. Asterisks indicate significant differences between control and
stimulation epochs (n = 5 cells tested during spontaneous and tail pinch-
evoked activity, repeated-measures ANOVA with Bonferroni post-hoc test).
(E) Spectrogram of hippocampal LFP in LM during sine stimulation of the
MS. Red: mean firing rate of a simultaneously recorded MS unit (same y axis
scale as the spectrogram). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 10−4.
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this effect at a finer timescale, we used wavelet decomposition to
identify theta epochs within each control and stimulation epoch:
Each sample was classified as theta-dominated if the scale corre-
sponding to the maximal coefficient of the wavelet decomposition
fell into theta band (2–6 Hz for anesthesia). We found that the
proportion of theta-dominated samples per epoch was significantly
increased by optogenetic stimulation of MS cholinergic neurons in
all mice (median proportion increase +0.33, P < 10−32, n = 296
trials; n = 7 mice, range: +0.08 to +0.64; see also Fig. S5).
In waking, freely moving mice, MS stimulation significantly de-
creased the power in the slow oscillation (0.5–4 Hz; −1.5 dB, P <
10−18) and supratheta (10–25 Hz; −1.6 dB, P < 10−38) bands (Fig. 3
B and C). In contrast to that in anesthetized mice, theta power
(4–10 Hz) in waking, freely moving mice was moderately but sig-
nificantly decreased (median change −0.8 dB, P < 10−28, n = 417
trials, n = 4 mice, range −0.2 to −1.4 dB). However, the theta/slow
oscillation ratio increased significantly (median: +15%, P =
0.0024). In addition, the median proportion of theta-dominated
samples per epoch increased from 0.30 in control to 0.43 in stim-
ulation epochs (P < 10−7; see also Fig. S5). Therefore, even though
theta power was decreased, the stronger effect on peri-theta bands
concurred to increase relative theta prominence in the LFP.
In two mice, recordings were performed in both anesthetized
and behaving conditions (example in Fig. 3B). Changes in these
mice reflected the group effects presented above and further
demonstrated the differential effect of cholinergic stimulation on
theta oscillation between anesthetized and drug-free animals.
Cholinergic activation effects on gamma-band oscillations were
largely similar to those on theta-band oscillations, albeit with
lower magnitude. Under anesthesia, the slow gamma oscillations
(<40 Hz) increased in multiple layers, whereas gamma power
(both slow, 30–70 Hz and midgamma, 70–100 Hz) decreased in
waking animals (Fig. S6 A–C). Theta phase modulation of gamma
power was not altered by optogenetic stimulation (Fig. S6D).
Effect on hippocampal LFP coherence. The theta-promoting effect of
MS stimulation was further confirmed by coherence analysis
across hippocampal layers (Fig. 4). In particular, stratum radia-
tum (Rad)-LM coherence increased at 3–4 Hz during stimula-
tion under anesthesia and in the 2- to 7-Hz band in behaving
animals [Fig. 4A and Fig. S3B; median change in theta band:
+0.09 in anesthetized animals (2–6 Hz), P < 10−25, individually
significant in six of seven animals; +0.06 in behaving animals
(4–10 Hz), individually significant in four of four mice]. The MS
stimulation-induced coherence increase in theta band under an-
esthesia (2–6 Hz) was significant across all layer pairs, whereas in
the behaving animal (4–10 Hz) it was confined to Rad–LM, ori-
ens–LM, and oriens–pyramidal layer pairs (Fig. 4B). The induced
coherence increase in behaving animals was confined to fre-
quencies below 7 Hz, indicating that cholinergic activation of the
hippocampus selectively affected the slow form of theta oscil-
lations (31). The induced power and coherence changes of the
LFP described above were largely confirmed by analyzing spectral
changes of current source density signals as well (Fig. S7).
To examine the impact of the frequency of MS stimulation, we
compared trials with 1-, 4-, 8-, and 12-Hz trains. In no experi-
ment did we observe that the frequency of the hippocampal LFP
followed the frequency of MS stimulation (Fig. 1E and Fig. S8).
In several cases, increasing the frequency of stimulation in-
creased the magnitude of power changes (Fig. S8). This effect is
likely due to the fact that faster stimulation induced more spikes
and therefore higher levels of ACh released from the cholinergic
terminals in the hippocampus (36).
State dependence of MS stimulation effect. Visual inspection of the
LFP traces indicated that the relative magnitude of the MS
stimulation-induced effects depended on background hippo-
campal activity. Because the strongest effect was the suppression
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Fig. 2. MS stimulation suppresses hippocampal sharp wave ripples. (A) Ex-
ample of hippocampal LFP in the pyramidal layer and stratum radiatum
displaying SPW-R (arrows) before the onset of optogenetic stimulation.
(Inset) Magnification of a detected ripple. (B) PoststimulusQ:12 time histogram of
ripple occurrence, before, during, and after 10-s sine stimulations at 1–12 Hz,
recorded in the same mouse under urethane anesthesia (Left, n = 77 trials)
or during free behavior (Right, n = 128 trials). (C) The mean incidence of
ripples is significantly decreased during stimulation in both urethane anes-
thesia (n = 6 mice) and freely moving conditions (n = 8 mice). Bars/error bars,
medians and quartiles for all animals; paired dots, individual mice.
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Fig. 3. MS stimulation exerts a selective effect at theta and peri-theta
frequencies in both anesthetized (Left) and behaving (Right) mouse. (A)
Example of hippocampal LFP from five layers. Blue: MS sinusoidal stimula-
tion. (Lower) magnified view of 3 s from control and stimulation epochs. (B)
Spectrograms of LFP recorded in LM in the same mouse under both con-
ditions before, during, and after 10-s sine stimulation (median of n = 71
trials in anesthesia, n = 82 in behaving). LFP was whitened for better visu-
alization of higher frequencies. (Lower) Zoom on lower frequencies. (C) LFP
power change in hippocampal layers (median of all trials, n = 296 in seven
anesthetized mice, n = 417 in four behaving mice). Arrow and dotted line
indicates the spared (least suppressed) frequency (∼6 Hz). DG, dentate gyrus;
LM, stratum lacunosum-moleculare; Or, stratum oriens; Pyr, pyramidal layer;
Rad, stratum radiatum.
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of SPW-Rs, we segregated trials into two groups: those display-
ing at least one ripple event during the control period (10 s
preceding the onset of stimulation, “ripple trials”) and those
without ripples and with a dominant power in the theta band
(“theta-dominant trials”). Because theta and SPW-Rs do not
rapidly alternate (37), the presence of SPW-Rs in the prestimu-
lation epochs can be taken as an indication of a different overall
state compared with epochs with prominent theta oscillations. In
anesthetized animals, LFP power in LM showed a larger relative
effect of stimulation in ripple trials than in theta-dominant trials
(Fig. 5 A and B; theta/slow oscillation ratio in ripple trials: +402%,
P < 10−11, n = 69 trials vs. theta-dominant trials: +155%, P < 10−6,
n = 84 trials). The differential effect of stimulation was also ap-
parent in the changes of dominant frequency. In ripple trials, the
median frequency shifted from a slow-oscillation range to theta
band (from 1.1 to 3.8 Hz, P < 10−10), whereas stimulation did not
affect the median frequency in theta-dominant trials (3.7 Hz in
both control and stimulation epochs; P > 0.1; Fig. 5B).
MS stimulation also exerted a background state-dependent dif-
ferential effect in behaving mice. In ripple trials, MS stimulation
induced a global decrease in LFP power with a relative sparing at
∼6 Hz, resulting in a moderate but significant increase in the theta/
slow oscillation ratio (Fig. 5 C and D; +27%; P < 10−11, n = 165
trials) and also increased theta proportion during the stimulation
epoch (Fig. 5D). The dominant frequency increased significantly
from 3.8 Hz to 6 Hz during stimulation (P = 0.0012; Fig. 5D). In
contrast, during theta-dominant trials the theta/slow oscillation ratio
and the proportion of theta samples were not significantly changed,
and theta frequency was significantly decreased (from 7.3 Hz to 6.9
Hz, P < 10−3). The power in the supratheta (10–25 Hz) band was
significantly reduced in both ripple (−47%, P < 10−23) and theta-
dominant (−21%, P < 10−11) trials.
It may be argued that SPW-Rs events are more likely followed
by theta epochs and, conversely, epochs with high theta power
may be more likely followed by epochs with low theta power. To
control for such potential sampling bias, we compared pairs of
consecutive 10-s epochs of spontaneous activity in the same way
as control vs. stimulation epoch pairs were analyzed. Epochs
were pseudorandomly chosen by shifting the analyzed epochs by
−20 s (i.e., comparing a “pre” interval located −30 to −20 s
before stimulation onset to a “post” interval located −20 to −10 s
before the stimulation onset). The lack of significant changes in
these control analyses confirmed the validity of our statistical
analyses of the MS-induced effects (Fig. S9). In summary,
optogenetic activation of MS cholinergic neurons was more
effective in the absence of background theta activity. When
background epochs were already dominated by high theta power,
MS stimulation induced only moderate or no effects.
Behavioral Effects of MS Stimulation. To assess the behavioral
correlates of the physiological effects observed on hippocampal
activity, we measured locomotor activity on a linear track or in
an open field in three behaving mice equipped with movement-
tracking light-emitting diodes during stimulation (Fig. 6). Con-
sidering the dichotomy of the MS stimulation effect depending
on background LFP activity (discussed above), we similarly
segregated LFP epochs into ripple trials vs. theta-dominant tri-
als. During ripple trials, associated with lower locomotor activity,
MS stimulation significantly increased speed in two of the three
mice. In contrast, in theta-dominant trials, speed was decreased
significantly during stimulation compared with control epochs in
two of the three mice. Therefore, the dichotomous effects on
behavior were consistent with the effects on theta power de-
scribed above. The correlations between locomotion speed and
theta power and speed and theta frequency were preserved
during MS stimulation (Fig. 6C). These findings indicate that
optogenetic cholinergic activation did not alter the relationship
between theta and behavior.
Discussion
Optogenetic stimulation of the cholinergic septal neurons in-
duced theta and gamma oscillations in the urethane-anesthetized
mouse. However, in waking, exploring mice the impact of stim-
ulation on theta and gamma oscillations was less expressed and
largely masked by the faster, noncholinergic form of theta. The
strongest effects of cholinergic stimulation were observed on
abolishing SPW-Rs and reducing the power of slow and supra-
theta oscillations under both anesthesia and waking state. Thus,
a main effect of ACh in theta oscillations seems to be the re-
duction of competing nontheta mechanisms.
The most consistent effect of optogenetic activation of septal
cholinergic neurons was the suppression of SPW-Rs (Fig. 2). Be-
cause such an effect was observed in every session in both anes-
thetized and waking animals, SPW-R suppression most clearly
illustrates the effectiveness of optogenetic stimulation. These
findings support the hypothesis that SPW-Rs are initiated by the
excitatory recurrent collaterals of CA3 pyramidal neurons when
subcortical controlling neuromodulatory transmitters are reduced
(14). ACh may attenuate the spread of such excitation by reducing
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the release of glutamate from the presynaptic terminals of CA3
neurons (38, 39). In support of this hypothesis, adding the
muscarinergic drug carbachol to the perfusion solution in in vitro
investigation also abolishes spontaneously occurring SPW-Rs
(16). Alternatively, or in addition, suppression of hippocampal
axo-axonic neurons by transiently bursting septal GABAergic
neurons may initiate SPW-Rs (40). This suggestion, however,
leaves open the question of why a specific subset of septal in-
hibitory cells bursts during reduced cholinergic activity in the
absence of theta oscillation. Overall, these findings can explain
the competing, antagonistic relationship between SPW-Rs and
theta oscillations (14).
Our results provide direct support for the role of ACh in en-
hancing theta oscillations (20) and the distinction between cho-
linergic-muscarinergic and noncholinergic mechanisms of theta
oscillations (31). ChR2-expressing cholinergic septal neurons
faithfully followed the frequency of optogenetic stimulation, al-
though frequency attenuation was obvious above 10 Hz. However,
the frequency of induced LFP theta oscillations was independent
of the entrainment frequency of septal cholinergic cells (Fig. 1).
The lack of frequency-driving ability of cholinergic neurons is not
surprising in light of the slow, second messenger-mediated
mechanism of muscarinic receptors (41). Increasing the frequency
of optogenetic stimulation simply increased theta power; this ef-
fect can be explained by the higher discharge rates of the septal
cholinergic cells. Frequency control of theta oscillations, instead,
may depend on the rhythmic firing patterns of septo-hippocampal
GABAergic neurons (26, 28), which terminate exclusively on
hippocampal inhibitory interneurons (42).
Another robust effect of optogenetic activation of MS cholin-
ergic neurons in both anesthetized and behaving mice was the
suppression of the power of slow oscillations (Fig. 3). These find-
ings are similar to stimulation of basal forebrain cholinergic neu-
rons, which reduced LFP power in the primary visual cortex in the
1- to 5-Hz band (43). One might argue that the reduction of hip-
pocampal power in this band simply reflected changes in volume-
conducted slow-frequency signals from the neocortex. However,
previous work has demonstrated that slow oscillations also affect
hippocampal circuits, as reflected by the entrained firing patterns
(44, 45). Furthermore, MS cholinergic neurons do not project
outside the limbic system (46), and thus their activation is not
expected to exert a direct impact on neocortical activity. In addition
to SPW-Rs and slow oscillations, optogenetic stimulation of the
MS also suppressed power in the supratheta frequency band. These
observations parallel the competing effects between theta and
supratheta band activity because termination of theta-associated
exploration in the intact animal is regularly coupled with enhanced
“beta” power (47). The mechanisms of the suppressive effects of
ACh on these oscillations are likely similar in the hippocampus and
neocortex (43) and may be mediated, at least partially, by pre-
synaptic M2 cholinergic receptor-mediated blockade of GABA
release from basket and other interneurons (48).
Optogenetically induced activation of cholinergic neurons con-
sistently increased low-frequency theta power and across-layer theta
coherence in the anesthetized mouse, independent of whether
stimulation occurred in the absence or presence of ongoing spon-
taneous theta activity (Figs. 3 and 4), as expected under the
framework of the cholinergic model of theta generation (31, 49). A
related interpretation of the differential effects of optogenetic
stimulation of MS during anesthesia and waking is that the overall
tone of ACh is lower under urethane than in the waking animal (50,
51). Thus, optogenetically assisted increase of cholinergic activity
could increase ACh release effectively in the anesthetized mouse, as
illustrated by the robust power changes in various frequency bands,
but the same stimulation would exert fewer effects in the waking
animal when levels of ACh are already high. The largest induced
effect was observed in LM, a layer with a high density of cholinergic
terminals (52) that were confirmed to be expressing ChR-2 in our
immunostaining experiments. The same stimulation exerted a less
clear effect on theta oscillations in the drug-free, behaving animal,
because theta seen during movement is largely noncholinergically
mediated, whereas the cholinergic input provides a background of
sensory input-related drive to the hippocampus during movement.
The effect of MS optogenetic drive was still observed by a signifi-
cant increase of theta coherence between stratum Rad and LM
below 7 Hz. These observations agree well with noncholinergic and
cholinergic distinctions of theta oscillations related to motor and
sensory integration, respectively (53). Overall, our findings provide
perhaps the best example to date for a competition between cho-
linergic and noncholinergic types of theta rhythms during move-
ment. They also demonstrate that the observed relationship between
optogenetic stimulation of septal cholinergic cells and LFP power
changes was not mediated by changes of motor behavior, because
optogenetic stimulation of MS did not exert a consistent effect on
locomotion speed, supporting previous observations (54).
Overall, cholinergic activation suppressed SPW-Rs entirely,
strongly reduced the power of slow oscillations and supratheta
frequency oscillations, and increased theta power and coherence
when the background activity contained little theta power. The
relative enhancement of theta activity was thus largely due to the
suppression of frequencies surrounding the theta band. In con-
trast, optogenetic activation brought about very little change in
any frequency band when the background was characterized by
high theta power. These results suggest that in the exploring and
ambulating animal ACh release already maximally activates
muscarinic receptors and, therefore, additional activation of
septal cholinergic neurons has little impact.
Methods
Details on experimental procedures are provided in Supporting Information.
Briefly, we used ChAT-Cre transgenic mice (n = 23) expressing ChR2 in their
cholinergic neurons. The cre-dependent ChR2-containing construct was delivered
to the MS either by viral gene transfer or by crossing the ChAT-Cre line with
a ChR2-carrying floxed reporter line. ChAT-Cre mice injected with a control viral
vector containing only the fluorescent reporter YFP were used as control for the
effect of light (n = 3). Optical stimulation was achieved by transmitting light
from a 473-nm laser source via an optic fiber to the MS. Both square pulse and
sine wave stimulation were applied at frequencies from 0.5 to 20 Hz (pulse) or
0.5–12 Hz (sine). Multisite silicone probes were used for recording hippocampal
local field potentials from several layers of the CA1-dentate axis in the dorsal
hippocampus. LFP signal from all layers was spectrally decomposed and effect of
stimulation on various frequency bands was determined before and after MS
stimulation in both anesthetized and freely moving mice.
speed in control (cm/sec)
sp
ee
d 
du
rin
g 
st
im
ul
at
io
n
(c
m
/s
ec
)
sp
ee
d(
cm
 /s
ec
)
p<10-3
control
stimulation
Ripple-trials Theta-trials
control
stim
A
C
speed (cm/sec)
Th
et
a 
po
w
er
 (m
V
2)
speed (cm/sec)
D
om
in
an
t f
re
qu
en
cy
 in
th
et
a-
do
m
in
at
ed
 s
am
pl
es
 (H
z)
B
0 2 4 6 8 10 12
0
2
4
6
8
10
0 2 4 6 8 10 12
0
0.02
0.04
0.06
0.08
0.1
0 2 4 6 8 10 12
4
6
8
10r2=0.26, p<0.01
r2=0.40, p<10-4
r2=0.48, p<10-4
r2=0.31, p<10-3
0
1
2
3
4
5
6
p<10-4
Fig. 6. Effect of MS stimulation on locomotor behavior. (A) Mean loco-
motion speed during control and stimulation epochs. Each dot is a single
trial; colors: data for three individual mice. (B) Effect on mean locomotor
speed during ripple trials (n = 90, three mice pooled) and theta-dominant
trials (n = 129). (C) Correlation between speed and theta power (Left) or
theta-dominant frequency (Right) in mouse 2, in control (black dots and line
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coefficient and P values are indicated.
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SI Methods
Animals.A total of 26 adult mice (2–7 mo) of both sexes were used
in this study. ThreeQ:1 transgenic mouse strains were used: 14 mice
expressing the Cre-recombinase under the control of the choline
acetyl-transferase promoter (ChAT-Cre, Jackson Labs strain
006410, or GENSAT GM60) were injected with Cre-dependent
Channelrhodopsin2 (ChR2) or control viral vector (discussed
below), whereas 9 mice were the offspring of the ChAT-Cre line
crossed with the Ai32 reporter line carrying a Cre-dependent,
enhanced YFP (EYFP)-tagged ChR2(H134R)-containing ex-
pression cassette (Allen Institute for Brain Research, or Jackson
Labs, strain 12569). Three mice were offspring of ChAT-Cre mice
crossed with Cre-reporter line Ai27, bearing a Cre-dependent
ChR2(H134R)-tdTomato construct (Allen Institute) (see ref. 1 for
details about Ai32 and Ai27 mouse strains). All experiments were
performed in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals, the Institutional
Ethical Codex, Hungarian Act of Animal Care and Experimen-
tation (1998, XXVIII, section 243/1998), and the European Union
guidelines (directive 2010/63/EU), and with the approval of the
Institutional Animal Care and Use Committees at Rutgers Uni-
versity, New York University, the Institute for Experimental Med-
icine of the Hungarian Academy of Science, and the Center for
Interdisciplinary Research in Biology. All mice were housed in
12:12 light/dark cycle. Water and food were available for ad libitum
consumption. All efforts were made to minimize pain and suffering
and to reduce the number of animals used.
Surgery.General anesthesia was induced with isoflurane inhalation.
For acute recordings, anesthesia was maintained with urethane
injection (1–1.5 mg/kg, i.p. initial injection, supplemented if nec-
essary up to 2.2 mg/kg). For survival surgery (injection of virus, or
implantation of probes and optic fibers), anesthesia was main-
tained with one i.p. injection of ketamine–xylazine (120 mg/kg and
16 mg/kg, respectively), followed by isoflurane inhalation delivered
through a mask mounted on the stereotaxic apparatus. Body
temperature was kept constant with a heating pad.
Virus injection. The surgeries were performed inside an isolation
cabinet under biosafety level-2 (BSL-2) confinement or in a BSL-2
virus injection facility. BrieflyQ:2 , the skull was exposed under anti-
septic conditions using local anesthesia with bupivacaine/lido-
caine and a hole was drilled above the medial septum (MS)
[anteroposterior (AP) +0.98 mm from bregma, mediolateral
(ML) +0.9 mm, 14° angle insertion, or AP +0.8 mm, ML
+0.7mm, 10° angle insertion or AP +0.7–0.9 mm, midline in-
sertion at 0° angle]. A glass pipette (30- to 50-μm tip) connected
to a Nanoject II/Nanoliter 2000 microinjector (Drummond Sci-
entific Co. WPI Inc.), or alternatively, a cannula connected to a
10-μL Hamilton syringe was used to inject 0.05–0.7 μL of virus
solution at one to five different depths between 3.8 and 4.6 mm
(14° angle insertion) or between 2.8 and 4 mm (10° angle in-
sertion), or at 3.0–3.4 mm (midline, 0° insertion), over 10–30 min.
After injection the pipette was removed slowly (0.1 then 0.5-mm
steps, 10-min waiting periods between each), the scalp was su-
tured, and injected mice were housed in BSL-2 quarantine for
2–4 wk before experimentation.
Acute and chronic implantations. The scalp was shaved after local
anesthesia with bupivacaine/lidocaine and the skull was exposed
in antiseptic conditions. Stereotaxic locations of the MS (AP +0.8
mm, ML +0.7 mm and 10° angle, or ML 0 mm and 0° angle
insertion) and hippocampus (AP −1.7 to −2.5 mm from bregma,
ML −1 to −2 mm) were marked on the skull. Two holes were
drilled over the cerebellum to insert the ground and reference
miniature screws. Craniotomies were performed at marked lo-
cations, and dura was gently removed. After implantation of
probes and optic fibers (discussed below), a paraffin–wax mixture
was used to seal the craniotomies. For chronic implantations,
extra steps were performed: One or two extra support screws
were inserted in opposite skull plates and implants were secured
to the skull using dental cement encompassing all screws, and
protected by a grounded copper mesh. Appropriate suture and
postoperative care of the wounds was ensured, and recordings
began after 1 wk of recovery (see ref. 2 for detailed procedures of
chronic surgery and recordings in rats).
Viral Constructs.Two adeno-associated viruses (AAV) were used, one
bearing ChR-2 with a YFP reporter and a control virus bearing only
the YFP reporter. Both Q:3viruses are based on the same double-floxed
inverse ORF technology designed by Karl Desseiroth and used
with his permission (www.stanford.edu/group/dlab/optogenetics/
sequence_info.html#dio): The ChR-2 virus EF1a.DIO.hChR2
(H134R)-EYFP.WPRE.hGH construct was packaged into AAV
serotypes 2, produced at Vector Biolabs and a gift from Tibor
Koos, or serotype 5, purchased form Penn Vector Core. The
control virus, EF1a.DIO.EYFP.WPRE.hGH (27056; Addgene),
was packaged into AAV serotype 1, bought from Penn Vector
Core, a gift from Marco Diana, and diluted three times in sterile
PBS before use.
Silicon Probes and Optic Fiber Implants. In the hippocampus, linear
multichannel silicon probes (16 or 32 sites, 50- or 100-μm spacing;
NeuroNexus) were inserted across the CA1–DG axis, at a 2.1- to
2.5-mm depth in 17 animals. In three animals, 16-site tetrode-
like probes (2 × 2 or 4 × 1 tetrode; NeuroNexus) were mounted
on a microdrive (see ref. 2 for microdrive details), inserted above
CA1 pyramidal layer (1-mm depth) and progressively lowered
during recovery down to the pyramidal layer (recognized by the
presence of ripples and stronger unit activity). Silicon probes
were painted with 2% DiI solution (Sigma) to facilitate the ex
vivo localization confirmation. In the MS, for optogenetic stim-
ulation only (16 animals), 125-μm-diameter optic fibers with a
50- to 105-μm core (Thorlabs) were implanted at a 3.0- to 3.5-mm
depth (depending on the stereotaxic angle chosen). Before
surgery, the optic fibers were stripped from the buffer layer and
connectorized with 1.25-mm ceramic ferrules (extracted from LC
connectors; Thorlabs). A Q:4pencil-shaped tip was obtained by
etching 30′ in hydrofluoric acid (Sigma) to facilitate the insertion
in the brain. For recording entrained cells in the MS together
with optogenetic stimulation (four animals), custom-made
optrodes were used: 10- to 50-μm core optic fibers (Thorlabs)
were stripped from buffer layer and progressively etched down to
a 2- to 10-μm tip in hydrofluoric acid before being attached to
12- to 16-site tetrode-like silicon probes (NeuroNexus Tech) by
UV light-curing epoxy (see refs. 3 and 4 for optrode construction
details). Optrodes were lowered to 2.8 mm and then pro-
gressively until typical MS activity was encountered in response
to tail pinch [local field potentials (LFP) theta rhythm, presence
of theta-on or theta-burst unit activity].
Optogenetic Stimulation. Light from Q:5a 473-nm diode-pumped solid-
state (DPSS) laser (Dreamlasers) was collimated with a fiberport
(Thorlabs) or delivered by a 475-nm laser diode light source (FLS-
475 nm–20 mW; DIPSI) into a custom patch cord (Thorlabs)
connected to the brain-implanted optic fiber. Light intensity was
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driven by analog modulation of the DPSS power supply, using
a Master-8 pulse stimulator (AMPI) or a MATLAB-controlled
DAQ-board (National Instruments or Measurement Computing
Corp.) to generate square or sinusoidal pulses. For stimulation only
of MS, maximum light intensity (crest of the sine wave, or plateau
pulse amplitude) was adjusted using a photodiode power sensor
coupled to a power meter (S130A and PM30 or S130C and
PM100USB; Thorlabs), taking into account the patch cord-to-fiber
coupling (measured before implantation of the fiber), to obtain
a maximum of 5–10 mW at the tip of the fiber in the brain. For
recording of entrained cells in MS using optrodes, owing to etching
and diffraction of light by epoxy the maximum light at the tip of the
fiber was <0.6 mW. Pulse trains consisted of 10- to 100-ms pulses
delivered at various frequencies ranging between 0.5 and 20 Hz.
During sine wave stimulation 0.5- to 12-Hz sinuses were delivered
for 5–60 s.
Electrophysiological Recordings. Extracellular signal was amplified
(20×) with a VLSI headstage (Plexon) and acquired continuously
at 32.5 kHz using a multichannel DigiLynx system (Neuralynx)
or amplified, multiplexed, and acquired continuously at 20 kHz
using a multichannel KJE-1001 system (5) (Amplipex) and stored
for offline analysis (discussed below). Twelve animals underwent
urethane acute recordings only (4 for MS-cells entrainment and
3 mice for control stimulation). Five animals underwent chronic
recordings only. Two animals underwent recordings during the
chronic implantation (during isoflurane anesthesia), followed
by freely moving chronic recordings. One animal underwent
chronic recordings followed by urethane acute recordings. For
chronic recording, after postoperative recovery animals were
recorded in their home cage during sleep, alert immobility, or
actively awake (grooming, sniffing, etc.) and/or during the ex-
ploration of a different environment (1-m × 7-cm linear track,
baited with sucrose solution or water at each end, or a 60- × 60-cm
open field arena). Before linear track sessions mice were water-
deprived for 1 d. Speed was monitored by video tracking coupled
to the recording system.
Histological Processing. ToQ:6 confirm probe track location, animals
were perfused transcardially under deep anesthesia with saline
followed by fixative [4% paraformaldehydeQ:7 (PFA) or 10% for-
maline solution]. Brain was removed and postfixed overnight in
fixative then rinsed in PBS and cut to 60- to 80-μm-thick coronal
slices using a vibratome (VT1200; Leica). Slices were mounted in
VectaShield (Vector Laboratories) to confirm probe track (aided
by DiI) and optic fiber tracks.
For immunostaining, mice were deeply anesthetized with over-
dosed urethane and perfused transcardially by saline followed either
by 4% PFA or by the Sloviter protocol [i.e., 2% PFA in acetate
buffer (pH 6.5) for 3 min followed by 2% PFA in borate buffer (pH
8.5) for 40 min]. After perfusion brains were removed and stored in
fixative solution overnight. Then, 50-μm sections were prepared on
a vibrotome (Leica). ThenQ:8 , sections were washed in 0.1 M phos-
phate buffer (PB), cryoprotected overnight in 30% sucrose dis-
solved in 0.1 M PB, and freeze-thawed in aluminum foil boats over
liquid nitrogen to enhance penetration of the antisera. Next, after
several changes of PB, the sections were transferred into Tris-
buffered saline (TBS, pH 7.4). All of the following washes and
antisera dilutions were carried out in TBS. Sections were incubated
in primary antibody solution for two nights at 4 °C. Then, primary
serum was washed, followed by incubation in secondary antibody
solution for 3 h at room temperature, followed by extensive
washing. Finally, sections were mounted on glass slides and cov-
ered by Vectashield.
Antibodies used were mouse monoclonal anti-ChAT primary
(1:500; see ref. 6) and Alexa-647 conjugated donkey anti-mouse
secondary (1:500) and chicken polyclonal anti-GFP primary
(1:2,000; Life Technologies) and Alexa-488 conjugated goat anti-
chicken secondary (1:500). In a subset of experiments, Rabbit
polyclonal anti-parvalbumin (1:1,000; Swant) and Alexa 594-
conjugated goat anti-rabbit secondary (1:500) were used. All
secondaries were purchased from Life Technologies.
Sections were examined either by an A1R or C2 confocal laser
scanning microscope (Nikon) or by an Axioplan-2 microscope
(Zeiss). Photomicrographs were taken by the fluorescent detector
of the A1R or C2 microscope, or by an Olympus DP-70 CCD
camera (Olympus) on the Zeiss microscope. Adjustments Q:9of look-
up tables of images were accomplished using Adobe Photoshop
CS (Adobe Systems Inc.).
Data Analysis.Data were visualized and processed using NeuroScope
and NDManager (7) (http://neuroscope.sourceforge.net and http://
ndmanager.sourceforge.net) and analyzed by MATLAB (Math-
Works) built-in or custom-built procedures. For unit detection in
MS, single units were isolated from the wideband signal using
the semiautomatic spike classifier KlustaKwik (http://klustakwik.
sourceforge.net) and further refined manually using the graphical
spike sorting application Klusters (7) (http://klusters.sourceforge.
net). Only units responding to light were analyzed. For analysis of
the effect in hippocampus, mice with an optrode in the MS (four
animals) are excluded from analysis, because the low light power
emanating from the tip of the optrode would be unlikely to re-
cruit a large and consistent enough population of cholinergic
neurons to affect the hippocampus efficiently and reproducibly.
Mutlilayer Spectral Analysis. Only mice with linear probe record-
ings and a full optic fiber in the MS are included in multilayer
analysis (10 anesthetized and 4 behaving mice). LFP signals were
extracted from broadband signals by low-pass filtering at 1.25
kHz; malfunctioning channels were manually identified and ex-
cluded from analysis. The anatomical localization of each channel
was then deduced from LFP features (ripples, sharp waves, and
theta and gamma depth profile) as well as histological confir-
mation of the probe track, and five channels were chosen in each
recording to represent the five layers analyzed: CA1 oriens, py-
ramidal, radiatum, stratum lacunosum-moleculare, and dentate
gyrus (DG). DG sublayers were not distinguished because all were
not similarly represented in all mice (in particular with 100-μm-
spacing linear probes). Current source density (CSD) was calcu-
lated as the second spatial derivative of the LFP (8) with a 100-
μm step. For CSD calculations, when needed, malfunctioning
channels were replaced by the interpolation of the surrounding
channels (in no case were there two contiguous bad channels).
For each stimulation epoch, a control period of the same dura-
tion situated right before the stimulation period was defined. For
each control and stimulation pair of epochs, the mean power and
coherence spectrum of LFP and CSD signals were computed
using multitaper Fourier analysis (9). When power ratios were
used (theta/slow oscillation or low/medium gamma), the cumu-
lative power over each band was normalized by the width of the
band in hertz. The global dominant frequency of each epoch was
taken as the frequency above 1 Hz with maximal power.
For theta-gamma phase-power coupling, LFP signal for each
epoch was filtered at theta frequency (2–6 Hz for anesthesia, 4–10
Hz for drug-free) and at the chosen gamma subbands (20–40 or
40–80 Hz for anesthesia and 30–70 or 70–100 Hz for drug-free
animals). Theta phase and gamma amplitude, respectively, were
extracted using a Hilbert transform. The modulation index was
computed using an adaptation of the Kullback–Leibler distance
between the observed distribution and a uniform distribution, as
described in ref. 10. The preferred phase was determined as the
theta phase bin in which the maximal gamma power was observed.
For wavelet analysis, raw signal was down-sampled to 200 Hz to
decrease computation load and then transformed by wavelet de-
composition using a linear wavelet scale. Number of scales was 400
ranging from 0.5 to 100 Hz (minimum and maximum frequency
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in the decomposition). The continuous wavelet transform of
the sampled time series xn is a convolution of it with the wavelet
function Ψ:
WnðsÞ=
XN−1
n′=0
xn′Ψ⋆

n′− n

δt
s

:
For the calculation of the wavelet power spectrum, the Morlet
wavelet was used (11):
Ψ0ðηÞ= π−1=4eiωoηe−η2=2:
For the wavelet decomposition the algorithm of Torrence and
Compo was used (12). For each control and stimulation epoch
we determined the theta-dominated LFP samples: time samples
in which the dominant frequency (corresponding to the scale with
maximal coefficient) was within theta band (2–6 Hz for anesthesia,
4–10 Hz for behaving). Theta proportion was calculated as the ratio
of the number of theta-dominated samples over the total number of
samples per epoch, and theta frequency as the median of the dom-
inant frequencies of theta-dominated samples. Within each control
and stimulation epoch theta segments were defined as segments
composed of ≥100 (500 ms) contiguous theta-dominated samples.
For state dependence, trials were segregated into two categories
based on the presence of ripples and on the dominant frequency
in the control epoch: “ripple trials” were characterized by the pres-
ence of at least one ripple in the control epoch, and “theta-domi-
nant trials” by the absence of ripple in the control epoch together
with the control epoch dominant frequency (from Fourier analysis)
within theta range (2–6 Hz for anesthesia, 4–10 Hz for behaving).
Ripple Analysis. For ripple detection, the 1.25-kHz down-sampled
LFP signal in the pyramidal layer channel was band-pass-filtered
(80–250 Hz) and ripple epochs were defined as periods during
which ripple-band power was greater than mean +2 SD, with
a peak power >4 SD and a minimum duration of 40 ms.
Thresholds were adjusted if needed after visual inspection of
each recording. Sessions where no ripples were detected in the
entire recording time were excluded from the ripple analysis
(such as isoflurane anesthesia recordings). In the remaining
sessions (from nine mice under urethane anesthesia, including
three control mice, and eight behaving mice) all trials were in-
cluded, independently of the presence or absence of ripples in
each individual control epoch. The occurrence of ripples was
then calculated for each mouse as the overall number of ripples
in all control/stimulation periods divided by the overall duration
of control/stimulation epochs.
Statistics.Unless otherwise stated, data are reported as medians
and 25–75% quartiles, and statistical significance was com-
puted using nonparametric paired tests when comparing con-
trol and stimulation epoch pairs (Wilcoxon’s signed rank test).
Bonferroni’s correction for multiple testing was used when
testing for five layers or 10 layer pairs. Statistics were com-
puted using MATLAB or Prism (GraphPad Software). For
circular data (preferred theta phase for theta–gamma cou-
pling), the statistics were calculated using the Circular Statis-
tics Toolbox for MATLAB (13). Data are presented as circular
mean and distribution, and statistical testing of stimulation
effect (control vs. stimulation epoch pairs) is computed by
testing the median of the stimulation–control circular distance
against 0 with a binomial test.
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Fig. S1. (A) Left-most panel: YFP immunostaining in the MS of a ChAT-cre mouse injected with cre-dependent ChR2-YFP virus. (Scale bar: 100 μm.) Right
panels: MS cells at higher magnification, showing the specific expression of YFP in ChAT neurons by triple immunostaining for YFP (green), ChAT (blue), and
parvalbumin (red). Arrowhead: YFP-positive, ChAT-positive, and parvalbumin-negative cell body. Arrows: YFP-negative, ChAT-negative, and parvalbumin-
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layer (Lower). Asterisk indicates a putative pyramidal cell soma. (Scale bars: 10 μm.) (C) (Left) Optrode track (dotted line), revealed by DiI staining in a mouse
with optogenetically entrained putative ChAT neurons in the MS. (Scale bar: 500 μm.) (Right) DiI-labeled track of hippocampal silicon probe spanning CA1 and
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higher magnification, showing the specific expression of the YFP in ChAT-positive neurons (arrows). Arrowheads are YFP-negative ChAT neurons. LS, lateral
septum; LV, lateral ventricle; MS, medial septum; NAcc, nucleus accumbens. (Scale bar: 20 μmQ:10 .) (B) Optogenetic stimulation of the MS (10-s-long sine wave at 1, 4,
8, or 12 Hz, median of 40 trials, maximum power output 9.4 mW) triggers no visible effect on the hippocampal LFP in urethane-anesthetized mice expressing YFP-
only in ChAT neurons (n = 3 animals, each column is a different mouse). Recording sites are linearly arranged with 100-μm spacing. (C) Optogenetic stimulation in
urethane-anesthetized ChAT-YFP mice fails to trigger three main effects observed in ChAT-ChR2-YFP animals: No change is observable in LFP power in stratum
lacunosum-molecular (LM, Left) or in Rad-LM coherence (Center). Optogenetic stimulation had no effect on ripple occurrence either (Right).
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Fig. S6. Effect of MS stimulation on hippocampal gamma power and theta–gamma coupling in anesthetized (left column) and behaving (right column) mice.
(A) LFP power changes in the gamma band in different layers (median power change, all trials pooled, n = 296 trials from seven anesthetized mice, n = 417
trials from four behaving animals). (B) LFP gamma power change in stratum lacunosum-molecular (LM), segregated according to the brain state during the
control epoch. The thick line represents the median across all trials (n = 69 and n = 84 for ripple and theta trials, respectively, under anesthesia, n = 165 and n =
159 in drug-free); thin lines correspond to individual animals. (C) Comparison of gamma change induced by optogenetic stimulation of the MS in five hip-
pocampal layers, in all trials, ripple trials (RIP), and theta trials. For each condition, the three top-left, top-right, and bottom-left color plots represent gamma
power change in the entire gamma band, slow gamma band, and mid-gamma band, respectively (median change across trials, decibels). The bottom right color
Legend continued on following page
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Fig. S7. Effect of MS stimulation on hippocampal CSD power and coherence in anesthetized (left column) and behaving (right column) mice. (A) CSD power
changes in different layers (all trials pooled). Arrow and vertical line indicate the spared theta frequency in Pyr layer for behaving animals. (Insets) Change in
the most affected layer (thick line, group; thin lines, individual animals): Pyr in anesthesia: median CSD power change in theta band +1.4 dB (P < 10−24, n = 296
trials, individually significant in six out of seven mice), and Rad in behaving mice: median CSD power change in theta band −2.7dB (P < 10−45, n = 417 trials,
individually significant in four of four mice). Note that the effect on Rad CSD in behaving animals is two- to fivefold stronger than in other layers, whereas the
effect in LFP power was in the same range across layers (see Fig. 3C). (B) CSD coherence between Pyr and LM in control (black) and stimulation (blue) epochs,
median of all trials in representative animals (n = 98 in anesthetized animals, n = 82 in behaving animals; interquartile area is shaded). (Insets) Pyr-LM co-
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Fig. S8. Effect of stimulation frequency. (A) LFP power changes induced by MS stimulation at 1, 4, 8, and 12 Hz (median of all trials, n = 73, 80, 73, and 70,
respectively, for anesthetized trials; n = 94, 135, 96, and 92, respectively, for behaving trials). Numbered horizontal lines represent the subbands quantified in B.
(B) Power changes in each spectrum subband: Subbands 1 (slow oscillation) and 3 (supratheta band) are significantly more affected at higher stimulation fre-
quencies, whereas theta band (subband 2) is not. Significant correlations of stimulation frequency with the effect on each subband are indicated (Spearman’s rho,
*P < 0.05, ***P < 0.001, ****P < 0.0001; the number of animals in which the correlation is individually significant is indicated). (C) Theta proportion change
displays a nonsignificant increase with stimulation frequency. (D) Theta frequency in theta-dominated samples in control (black outline) and stimulation (cyan
outline) epochs. Significant correlations of stimulation frequency with theta frequency in control, with theta frequency during stimulation, and with the effect on
theta frequency are indicated (spearman’s rho, **P < 0.01, ****P < 0.0001; the number of animals in which the correlation is individually significant is indicated).
We assume that higher frequency stimulation induced more spikes per unit time in the MS cholinergic neurons, and therefore enhanced the release of the
amount of acetylcholine. The slight tendency that 4- and 8-Hz stimulation exerted the maximum effects in anesthetized preparation warrants further in-
vestigation, however.
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Fig. S9. Shift analysis of trial segregation effect in behaving mice. Comparison of two 10-s-long epochs starting at 10 s and 20 s before MS stimulation. (A) LFP
power changes in all hippocampal layers for real control/stimulation epoch pairs (continuous lines) and shifted pre/post epoch pairs (dotted lines). (B) Color
plots of significance (log of P values computed from Wilcoxon’s rank sum test), computed for real control/stimulation epoch pairs (Upper) and for shifted pre/
post epoch pairs (Lower) for each frequency bin in each layer.
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Q: 1_In the sentence beginning “Three transgenic mouse strains” the nonstandard abbreviation “EYFP”
was defined as “enhanced YFP.” Please confirm this is correct or alter the definition.
Q: 2_In the sentence beginning “Briefly, the skull was exposed,” the abbreviations “AP” and “ML” were
defined, respectively, as “anteroposterior” and “mediolateral.” Please confirm this is correct or alter
the definitions.
Q: 3_In the sentence beginning “Both viruses are based” please give institutions and locations (city and
state/country) for gift givers Koos and Diana.
Q: 4_In the sentence beginning “A pencil-shaped tip,” please confirm that “30′” is correct.
Q: 5_In the sentence beginning “Light from a 473-nm” the nonstandard abbreviation “DPSS” was defined
as “diode-pumped solid-state.” Please confirm this is correct or alter the definition.
Q: 6_In the sentence beginning “To confirm probe track location” the nonstandard abbreviation “PFA”
was defined as “paraformaldehyde.” Please confirm this is correct or alter the definition.
Q: 7_Please state basis for all concentrations >1%, eg, (vol/vol).
Q: 8_In the sentence beginning “Then, sections were washed” the nonstandard abbreviation “PB” was
defined as “phosphate buffer.” Please confirm this is correct or alter the definition.
Q: 9_In the sentence beginning “Adjustments of look-up tables” that term was used to spell out the
nonstandard abbreviation “LUTs.” Please confirm this is correct or alter the term.
Q: 10_In Fig. S4 panel B has been labeled as “B1” but it appears that it should be “B.” Please update if
needed and provide a new Fig. S4.
AUTHOR QUERIES
AUTHOR PLEASE ANSWER ALL QUERIES
